-
Subject Areas on Research
-
A long-acting formulation of rifabutin is effective for prevention and treatment of Mycobacterium tuberculosis.
-
A prospective, randomized, double-blind study of the tolerability of rifapentine 600, 900, and 1,200 mg plus isoniazid in the continuation phase of tuberculosis treatment.
-
A randomized controlled trial of standard versus intensified tuberculosis diagnostics on treatment decisions by physicians in Northern Tanzania.
-
ATS Core Curriculum 2014: part I. Adult pulmonary medicine.
-
Access to quality diagnosis and rational treatment for tuberculosis: real-world evidence from China-Gates Tuberculosis Control Project Phase III.
-
Adherence to TB preventive therapy for HIV-positive patients in rural South Africa: implications for antiretroviral delivery in resource-poor settings?
-
Advances in basic and translational tuberculosis research: Proceedings of the first meeting of RePORT international.
-
Adventures within the speckled band: heterogeneity, angiogenesis, and balanced inflammation in the tuberculous granuloma.
-
Adverse outcome pathway for aminoglycoside ototoxicity in drug-resistant tuberculosis treatment.
-
Alcohol use and clinical manifestations of tuberculosis.
-
Antepartum or postpartum isoniazid treatment of latent tuberculosis infection.
-
Are free anti-tuberculosis drugs enough? An empirical study from three cities in China.
-
Are tuberculosis patients adherent to prescribed treatments in China? Results of a prospective cohort study.
-
Bacteremic disseminated tuberculosis in sub-saharan Africa: a prospective cohort study.
-
Central nervous system infection and cutaneous lymphadenitis due to Mycobacterium kansasii in an immunocompetent patient.
-
Clinical outcomes among patients with tuberculous meningitis receiving intensified treatment regimens.
-
Common Variants in the Glycerol Kinase Gene Reduce Tuberculosis Drug Efficacy.
-
Concordance of Drug-resistance Profiles Between Persons With Drug-resistant Tuberculosis and Their Household Contacts: A Systematic Review and Meta-analysis.
-
Consequential drug combinations for tuberculosis treatments.
-
Corticosteroids for tuberculous pericarditis: can we learn from variability?
-
Cost-effectiveness of alternative strategies for interferon-γ release assays and tuberculin skin test in tuberculous uveitis.
-
Costs and cost-effectiveness of four treatment regimens for latent tuberculosis infection.
-
Current issues in global tuberculosis control.
-
Cycloserine and Linezolid for Tuberculosis Meningitis: Pharmacokinetic Evidence of Potential Usefulness.
-
Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial.
-
Design, synthesis, and study of a mycobactin-artemisinin conjugate that has selective and potent activity against tuberculosis and malaria.
-
Diagnostic and therapeutic challenges.
-
Do clinical decision-support reminders for medical providers improve isoniazid preventative therapy prescription rates among HIV-positive adults? Study protocol for a randomized controlled trial.
-
Drug-resistant tuberculosis control in China: progress and challenges.
-
Exogenous reinfection of tuberculosis in a low-burden area.
-
Factors associated with non-completion of follow-up: 33-month latent tuberculous infection treatment trial.
-
Flu-like and Other Systemic Drug Reactions Among Persons Receiving Weekly Rifapentine Plus Isoniazid or Daily Isoniazid for Treatment of Latent Tuberculosis Infection in the PREVENT Tuberculosis Study.
-
Global tuberculosis control report.
-
How affordable are tuberculosis diagnosis and treatment in rural China? An analysis from community and tuberculosis patient perspectives.
-
Impact of Community-Based DOT on Tuberculosis Treatment Outcomes: A Systematic Review and Meta-Analysis.
-
Impact of an innovative tuberculosis financing and payment model on health service utilization by tuberculosis patients in China: do the poor fare better than the rich?
-
Implementation of Tuberculosis Intensive Case Finding, Isoniazid Preventive Therapy, and Infection Control ("Three I's") and HIV-Tuberculosis Service Integration in Lower Income Countries.
-
Intermittent tuberculosis treatment for patients with isoniazid intolerance or drug resistance.
-
Introduction of European priority review vouchers to encourage development of new medicines for neglected diseases.
-
Isoniazid preventive therapy in medium-incidence settings: the price is right.
-
Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort.
-
LONGITUDINAL FOLLOW-UP OF TUBERCULAR SERPIGINOUS-LIKE CHOROIDITIS USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.
-
Lack of consensus in the diagnosis and treatment for ocular tuberculosis among uveitis specialists.
-
Long-term remission for disseminated Mycobacterium avium-intracellulare complex associated with antibody deficiency.
-
Medicine. A portfolio model of drug development for tuberculosis.
-
Medium matters: modeling the impact of solid medium performance on tuberculosis trial sample size requirements.
-
Mitochondrial Impairment in Antibiotic Induced Toxic Optic Neuropathies.
-
Mitochondrial and immunoallergic injury increase risk of positive drug rechallenge after drug-induced liver injury: a systematic review.
-
Molecular Diagnostics for Mycobacterium tuberculosis Infection.
-
Molecular identification of streptomycin monoresistant Mycobacterium tuberculosis related to multidrug-resistant W strain.
-
Monitored isoniazid prophylaxis for low-risk tuberculin reactors older than 35 years of age: a risk-benefit and cost-effectiveness analysis.
-
Monitored isoniazid prophylaxis for low-risk tuberculin reactors.
-
Mortality before or during treatment among tuberculosis patients in North Carolina, 1993-2003.
-
Moving toward Tuberculosis Elimination. Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection.
-
Mycobacteria: treatment approaches and mechanisms of resistance.
-
Novel Regimens of Bedaquiline-Pyrazinamide Combined with Moxifloxacin, Rifabutin, Delamanid and/or OPC-167832 in Murine Tuberculosis Models.
-
Old drugs, new purpose: retooling existing drugs for optimized treatment of resistant tuberculosis.
-
Optimising pyrazinamide for the treatment of tuberculosis.
-
Over- and under-treatment of TB patients in Eastern China: an analysis based on health insurance claims data.
-
Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome in children.
-
Periprosthetic infections due to Mycobacterium tuberculosis in patients with no prior history of tuberculosis.
-
Policy changes and the screening, diagnosis and treatment of drug-resistant tuberculosis patients from 2015 to 2018 in Zhejiang Province, China: a retrospective cohort study.
-
Potential economic viability of two proposed rifapentine-based regimens for treatment of latent tuberculosis infection.
-
Potentiation of P2RX7 as a host-directed strategy for control of mycobacterial infection.
-
Pott's disease caused by Mycobacterium xenopi: case report and review.
-
Presumptive diagnosis and treatment of pulmonary tuberculosis based on radiographic findings.
-
Prevalence of Pre-Existing Hearing Loss Among Patients With Drug-Resistant Tuberculosis in South Africa.
-
Rapid molecular detection of tuberculosis and rifampin resistance.
-
Rate of resolution of histologically verified intracranial tuberculomas.
-
Reply to Seddon, Schaaf, and Hesseling.
-
Reply to Swindells et al.: Trials of Tuberculosis-Preventive Therapy in People with HIV Infection.
-
Risk of hearing loss among multidrug-resistant tuberculosis patients according to cumulative aminoglycoside dose.
-
Safety of 2 months of rifampin and pyrazinamide for treatment of latent tuberculosis.
-
Safety of rifampin and pyrazinamide for the treatment of latent tuberculosis infection.
-
Strategies for treating latent multiple-drug resistant tuberculosis: a decision analysis.
-
Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.
-
Successful cure of extensively drug-resistant pulmonary tuberculosis in a young child.
-
Successful treatment of disseminated BCG in a patient with severe combined immunodeficiency.
-
Tackling the unknowns of short-course rifapentine-based treatment for active tuberculosis: a decision analysis.
-
The Effect of an Innovative Financing and Payment Model for Tuberculosis Patients on Health Service Utilization in China: Evidence from Hubei Province of China.
-
The evolution of drug resistance in Mycobacterium tuberculosis: from a mono-rifampin-resistant cluster into increasingly multidrug-resistant variants in an HIV-seropositive population.
-
The impact of human immunodeficiency virus infection on drug-resistant tuberculosis.
-
The race to eliminate tuberculosis.
-
Three months of rifapentine and isoniazid for latent tuberculosis infection.
-
Translating tuberculosis research into practice: collaboration between academic researchers and public health departments in North Carolina.
-
Treating multidrug-resistant tuberculosis in community settings: a wise investment.
-
Tuberculoma of the choroid.
-
Tuberculosis patient expenditure on drugs and tests in subsidised, public services in China: a descriptive study.
-
Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings.
-
Unrecognised Mycobacterium tuberculosis bacteraemia among hospital inpatients in less developed countries.
-
Keywords of People